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Circadian rhythm disorders are a group of sleep conditions that involve a 
misalignment of an individual’s internal timekeeping system with that of one’s 
desired sleep-wake time. This desynchrony can compromise sleep health as well as 
the functioning of other organ system, and significantly diminish one’s quality of 
life. There are six well-defined circadian rhythm disorders that can be classified as 
either intrinsic or extrinsic, based on the underlying factors that contribute to the 
condition. Intrinsic circadian disorders include the following: 1) advanced sleep-
wake phase disorder, 2) delayed sleep-wake phase disorder, 3) irregular sleep-wake 
rhythm disorder, and 4) non-24-hour sleep-wake rhythm disorder. The two cir-
cadian disorders caused by external factors include 1) shift work disorder, and 2) 
jet lag disorder, both of which are due to behaviorally mediated misalignments of 
circadian system. This chapter serves to summarize these disorders, guide clinicians 
towards screening and evaluation of these conditions, and introduce basic treat-
ment strategies that can be applied by non-sleep medicine clinicians.
Keywords: circadian rhythm disorder, advanced sleep–wake phase disorder, delayed 
sleep–wake phase disorder, irregular sleep–wake rhythm disorder,  
non-24-hour sleep–wake rhythm disorder, shift work disorder, jet lag disorder, 
melatonin, phototherapy
1. Introduction: what every clinician needs to know
The intrinsic circadian system synchronizes basic physiologic functions such as 
temperature regulation, appetite, and hormonal homeostasis and is responsible for the 
stable sleep and wake states that occur at regular times with respect to day and night. 
The term circadian derives from the Latin words “circa,” meaning approximately, and 
“diem,” meaning day, which emphasize that the intrinsic cycle is usually not exactly 
24 hours in length [1]. The average circadian cycle length is generally 24.2 hours, which 
means that the cycle always requires entrainment to the environment because the 
day is exactly 24 hours long. Light is the most potent mechanism of entrainment, but 
meals and exercise also have an impact on entrainment [1–3] . Dysynchrony between a 
person’s internal circadian system and their desired wake and sleep periods can lead to 
one of 6 different types of circadian rhythm sleep–wake disorders (CRSWDs). These 
disorders can present clinically with symptoms of insomnia and/or excessive daytime 
sleepiness, along with impairments in cognitive, emotional, and social functioning. A 
key feature of these conditions is that re-alignment of the intrinsic circadian period to 
the desired circadian period leads to resolution of symptoms.
CRSWDs may be due to a primary problem with the circadian system, such as 
altered sensitivity of the circadian system to light, and genetic and/or age-related 
factors that disrupt the intrinsic period of the system.
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The diagnosis of CRSWDs can be difficult, due to the overlapping symptoms 
with other sleep disorders and medical conditions. Recognizing consistent patterns 
in abnormal sleep schedules is key to helping differentiate CRSWDs from other 
disorders. CRSWDs are primarily clinical diagnoses and use of a detailed sleep diary 
is an important part of the evaluation. Other objective measures such as actigraphy 
and melatonin measurements can supplement information obtained from the 
patient’s history [4]. Polysomnography is usually not indicated unless there is a 
suspicion for a comorbid sleep disorder, such as a sleep-related breathing disorder.
Management of circadian rhythm sleep–wake disorders involves a combination 
of behavioral interventions, light therapy, and timed melatonin therapy. Treatment 
is individualized to the specific circadian rhythm sleep–wake disorder [5] . The goal 
of therapy is to gradually realign the patient’s sleep and wake times with the desired 
schedule. The timing of light and melatonin therapies is critical to determining their 
biologic effects. The key biologic markers are the dim light melatonin onset (DLMO), 
which typically occurs approximately two hours prior to habitual sleeptime, and the 
core body temperature minimum (CBT-min), which typically occurs 2-3 hours prior 
to habitual wake up time. Exposure to light prior to the body temperature minimum 
will cause the circadian rhythm to delay (i.e. the next night, there will be a tendency 
to go to bed and wake up later). Light exposure after the core body temperature 
minimum will cause the circadian system to advance (i.e. the next night, there will 
be a tendency to go to bed and to wake up earlier). The effect of light is most potent 
when it is in the blue spectrum and administered close to the CBT-min. Melatonin 
has the opposite phase response relationship that light has; melatonin given prior to 
the CBT-min will cause the circadian rhythm to advance (i.e., the next night, there 
will be a tendency to go to bed and wake up earlier) whereas melatonin administra-
tion after the CBT-min will cause the circadian system to delay (i.e., the next night, 
there will be a tendency to go to bed and wake up later).
The International Classification of Sleep Disorders, third edition (ICSD-3), has the 
following three diagnostic criteria for all circadian rhythm sleep–wake disorders [6]:
1. A disrupted sleep–wake pattern, thought to be due to misalignment or mal-
function of the circadian system;
2. A complaint of insomnia, excessive sleepiness, or both;
3. Suboptimal performance in an important area of functioning (e.g. occupation, 
education, social life, mental or physical life).
2. Classification of the circadian rhythm sleep-wake disorders
Intrinsic CRSWDs include the following: 1) advanced sleep–wake phase disorder 
(extreme early bird), 2) delayed sleep–wake phase disorder (extreme night owl), 
3) non-24-hour sleep–wake rhythm disorder (drifting circadian rhythm), and 4) 
irregular sleep–wake rhythm disorder (no rhythm). The two circadian disorders 
caused by extrinsic factors are 1) shift work disorder and 2) jet lag disorder, both of 
which are due to behaviorally mediated misalignments of circadian system.
3.  Are you sure your patient has a circadian rhythm sleep-wake disorder? 
What should you expect to find?
Circadian rhythm disorders can result in clinically significant symptoms of 




drastic misalignment of one’s circadian clock with societal norms can often have 
implications for one’s emotional well-being and social functioning. There are 6 
major categories of circadian rhythm sleep–wake disorders which are grouped 
based on patterns of sleep time:
3.1 Advanced sleep–wake phase disorder (ASWPD)
ICSD-3 Diagnostic Criteria [6]:
1. An advance (early timing) in the phase of the major sleep episode in relation 
to the desired or required sleep time and wake-up time, (i.e. the patient feels 
sleepy too early and wakes up too early).
2. Symptoms are present for at least three months.
3. When the patient sleeps of his/her own accord, sleep quality and duration are 
improved with a consistent but advanced timing of the major sleep episode.
4. Sleep log and, whenever possible, actigraphy monitoring for at least seven days 
show a stable advance in sleep period. Both work/school days and free days 
must be included during the actigraphy monitoring period.
5. The patient’s symptoms are not better explained by another current sleep, 
medical, neurological disorder or mental disorder.
Clinical Characteristics: ASWPD is an intrinsic defect of the circadian system in 
which sleep duration and quality are normal, but where sleep and wake up times are 
earlier than desired or socially acceptable. Generally, the intrinsic circadian rhythm 
period is actually shorter than normal.
Patients with ASWPD often report that they are unable to stay awake past 7 PM 
and tend to wake up around 2-5 AM. If a patient is able to set their own schedule 
they will obtain adequate sleep and feel refreshed in the morning. However, since 
due to social obligations they often stay up later than naturally desired while 
still waking early. This can lead to a sleep deficit over time that leads to daytime 
sleepiness.
3.2 Delayed sleep-wake phase disorder (DSWPD)
ICSD-3 Diagnostic Criteria [6]: A delay (late timing) in the phase of the major 
sleep episode in relation to the desired or required sleep time and wake-up time (i.e. 
the patient does not feel sleepy at bed time and wakes up too late).
6. The symptoms are present for at least three months.
7. When patients sleep of their own accord, sleep quality and duration are im-
proved with a consistent but delayed timing of the major sleep episode.
8. Sleep log and, whenever possible, actigraphy monitoring for at least seven days 
show a stable delay in sleep period. Both work/school days and free days must 
be included during the actigraphy monitoring period.
9. The patient’s symptoms are not better explained by another current sleep, 
medical, neurological disorder or mental disorder
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Clinical Characteristics: DSWPD is one of the most common circadian rhythm 
sleep–wake disorders, often affecting adolescents and young adults when eveningness 
tendencies are typically the strongest. This is a defect of the circadian system whereby 
the sleep/wake cycle is misaligned with the patient’s desired schedule by more than 
2 hours. Individuals go to sleep and wake up at substantially later times than desired, 
which can lead to social consequences such as chronic tardiness at work or school. 
Delayed bedtimes (usually between 1 and 6 AM), coupled with early awakenings to 
meet social/occupational/academic obligations, result in a sleep debt that accumu-
lates over time. There is often a high prevalence of comorbid depression, and higher 
degrees of circadian misalignment correlate with greater severity of depression.
The intrinsic circadian period is generally longer than normal. DSWPD typically 
emerges during adolescence and can continue into adulthood.
3.3 Irregular sleep-wake rhythm disorder (ISWRD)
ICSD-3 Diagnostic Criteria [6]:
1. Chronic or recurrent pattern of irregular sleep and wake episodes throughout 
the 24-hour period.
2. Symptoms are present for at least three months.
3. Sleep log and, whenever possible, actigraphy monitoring for at least seven 
days, show no major sleep period and multiple irregular sleep bouts (at least 
three) during a 24-hour period.
4. The patient’s symptoms are not better explained by another current sleep, 
medical, neurological disorder or mental disorder.
Clinical Characteristics: ISWRD is characterized by a temporally disorganized 
sleep and wake pattern such that there are no clearly defined periods of wake and/
or sleep. Multiple sleep and wake periods can occur throughout the day, and usually 
consist of 3 or more short intervals, approximately 1-4 hours each. The longest 
period generally occurs in the morning between 2 and 6 AM; however, the distribu-
tion of sleep and wake periods can vary per individual. The total sleep duration 
throughout a 24-hour period is generally normal for the individual’s age. Because 
of the fragmented nature of sleep, individuals can experience frequent napping, 
excessive daytime sleepiness, and difficulty staying asleep at night.
3.4 Non-24 sleep-wake rhythm disorder (N24SWRD)
ICSD-3 Diagnostic Criteria [6]:
1. History of insomnia, excessive daytime sleepiness, or both, which alternate with 
asymptomatic episodes, due to misalignment between the 24-hour light–dark cycle 
and the non-entrained endogenous circadian rhythm of sleep–wake propensity.
2. Symptoms persist over the course of at least three months.
3. Daily sleep logs and actigraphy for at least 14 days, preferably longer for blind 
persons, show a pattern of sleep and wake times that typically delay each day.
4. The patient’s symptoms are not better explained by another current sleep, 




Clinical Characteristics: N24SWD, also known as non-trained rhythm disorder, 
is characterized by chronic cycles of sleep and wake that are not always synchronized 
with the 24-hour environment. There is a gradual, but consistent drift of sleep and wake 
times later into the day. Attempting to maintain a regular sleep–wake schedule can lead 
to symptoms of excessive daytime sleepiness, chronic fatigue, early morning awaken-
ings and insomnia. These symptoms alternate with days to weeks in which the patient is 
asymptomatic, owing to the patient’s endogenous circadian system coinciding with the 
external 24-hour cycle. Napping is common, and patients often report impairment of 
social and occupational functioning due to non-entrained sleep–wake schedule.
N24SWD occurs most often in blind individuals. Onset of symptoms usually 
occurs in 2nd or 3rd decade of life, and men are disproportionally affected com-
pared to women at a ratio of >2: 1 [7].
3.5 Shift work sleep-wake disorder (SWD)
ICSD-3 Diagnostic Criteria [6]:
1. Insomnia and/or excessive sleepiness, accompanied by a reduction of total 
sleep time, which is associated with a recurring work schedule that overlaps 
with the usual time for sleep.
2. Symptoms are present and associated with the shift work schedule for at least 
three months.
3. Symptoms cause clinically significant impairment in mental, physical, social, 
occupational, education, or other important areas of functioning.
4. Sleep log and, whenever possible, actigraphy monitoring for at least 14 days 
(work and free days) demonstrate a disturbed sleep and wake pattern.
5. The patient’s symptoms are not better explained by another current sleep, 
medical, neurological disorder or mental disorder.
Clinical Characteristics: Individuals who work night shift experience difficulty 
with sleep and alertness at desired times, and are at greater risk for the variety of 
adverse health outcomes associated with poor sleep. Shift workers generally report 
30-90 minutes less sleep compared to those not working shifts, and their sleep qual-
ity tends to be more fragmented and of poorer quality. Shift workers also experience 
difficulty falling and staying asleep, with as many as 20% of shift workers having 
clinically significant insomnia [8]. During waking hours, night shift workers are 
more prone to increased sleepiness, decreased neurocognitive function and more 
significant changes to mood than their non-night shift counterparts.
3.6 Jet lag disorder (JLD)
ICSD-3 Diagnostic Criteria [6]:
1. Insomnia or excessive daytime sleepiness associated with a reduction of total 
sleep time coinciding with jet travel across at least two time zones
2. Impaired daytime function, general fatigue, or somatic symptoms that begin 
within two days of travel
3. The sleep disturbance cannot be explained by another disorder.
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Clinical Characteristics: JLD occurs when an individual travels through 
time zones faster that the endogenous circadian rhythm can adjust, resulting 
in desynchrony between the external light–dark cycle and one’s internal clock. 
Symptoms of JLD include difficulty falling and staying asleep, excessive daytime 
sleepiness, generalized fatigue, impaired daytime performance, and various 
somatic symptoms (most commonly gastrointestinal) that begin 1 to 2 days 
post-travel [8].
In addition to number of time zones traveled, the severity of jet lag is affected by 
the direction of travel. Eastward travel leads to more difficulty with falling asleep 
and is more difficult to adjust to, while westward travel is more disruptive to sleep 
maintenance.
4.  How and/or why did the patient develop a circadian rhythm  
sleep-wake disorder? Which individuals are of greatest risk of 
developing a circadian rhythm sleep-wake disorder?
4.1 Advanced sleep-wake phase disorder (ASWPD)
Genetic studies have shown possible links to mutations in the PER2 and 
CSNK1D clock genes, both of which are inherited in autosomal dominant pattern 
[2, 3]. There is an estimated 1% prevalence, with males and females being equally 
affected. Older adults are more likely to have advanced tendencies. Other con-
tributing factors include decreased responsiveness to evening light, and increased 
responsiveness to morning light, both of which can shift the sleep–wake cycle 
earlier than desired.
4.2 Delayed sleep–wake phase disorder (DSWPD)
The pathophysiology of DSWPD is multifactorial [2, 3] l. It is hypothesized that 
certain exogenous factors, such as increased exposure to evening light and greater 
sensitivity to evening light may play a role in development of DSWPD. Genetic 
factors may play a role, but their exact contribution is less understood than is the 
case for ASWPD.
DSWPD typically emerges during adolescence and can continue into adult-
hood. Males and females seem to be affected equally. Peak age appears to be 
21 years old in males and 17 years old in females. There is a large variability in 
its reported prevalence, with population study estimates ranging from <1% up 
to 10% [1–3]. Patients with hepatic cirrhosis are also affected at much higher 
rates (33%).
4.3 Irregular sleep-wake rhythm disorder (ISWRD)
ISWRD is most commonly seen in individuals with neurodegenerative conditions, 
particularly those with Alzheimer’s disease and late-afternoon sundowning [1–3]. 
It is also more common in those with traumatic brain injury, in children with devel-
opmental delay, in patients with schizophrenia, and particularly in patients who are 
institutionalized. It is hypothesized that intrinsic circadian dysfunction, coupled with 
decreased exposure to external synchronizing agents such as light and social activity, 




4.4 Non-24 sleep-wake rhythm disorder (N24SWRD)
The etiology of N24SWD is related to disruption of the portion of the circadian 
system responsible for capturing photic stimuli in the retina. Pathologies that lead 
to vision loss often but not necessarily impact this system. Thus, N24SWD occurs 
most often in blind individuals, with reports of 50% of blind patients diagnosed 
with N24SWD and up to 70% of blind individuals having symptoms of chronic 
sleep disturbance [2, 3, 7]. Men are disproportionally affected compared to women 
at a ratio of >2:1. N24SWD is rare, but has been reported, in sighted individuals. In 
sighted individuals, N24SWD is thought to be a severe form of delayed sleep phase 
disorder where entrainment to light can no longer be effective [7].
4.5 Shift work sleep-wake disorder (SWD)
The mechanism behind SWD is thought to be governed by disruptions of 2 
physiologic processes [1–3]. The first is related to one’s homeostatic drive for sleep, 
which increases throughout wakefulness. The second is one’s intrinsic rhythmic 
oscillations for sleep and wake periods, which is governed by the circadian pace-
maker. This latter process is calibrated by environmental clues such as light. Both 
the homeostatic process and the circadian process are disrupted in SWD.
Individuals at greatest risk for SWD are those that work rotating night shifts, 
rather than permanent night shifts, because they are never able to adapt to a 
stable sleep–wake pattern [8]. In addition, those with other sleep comorbidities 
can have synergistic effects of sleep disturbance, which lead to symptomatic 
worsening.
4.6 Jet lag disorder (JLD)
JLD results from desynchrony between the external light–dark cycle and an indi-
vidual’s internal clock when travel across time zones occurs more quickly than the 
endogenous circadian rhythm can adjust. The prevalence of this condition is poorly 
defined [8]. Factors that affect jet lag severity include the direction of travel and 
number of time zones traveled, the person’s ability to sleep during travel, individual 
variations in circadian timing, presence of light cues at destination, and intake of 
alcohol and caffeine.
5.  What diagnostic studies will be helpful in making or excluding the 
diagnosis of a circadian rhythm sleep-wake disorder? What other 
diseases can mimic circadian rhythm sleep-wake disorders?
5.1 Advanced sleep-wake phase disorder (ASWPD)
ASWPD is a clinical diagnosis and should be suspected in individuals who have a 
history of early sleep onset and wake times. It is important to obtain a detailed sleep 
history that addresses sleep patterns, napping habits, and daytime symptoms of 
sleepiness, cognitive changes, or mood changes. Targeted questions should be asked 
about difficulty falling or staying asleep and sleep quality both during the patient’s 
current schedule and during times when he/she has followed the preferred sched-
ule. Obtaining collateral history from a bed partner is often useful.
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Patients with suspected ASWPD should keep a sleep log for at least 7 days, 
preferably 14 days, including both weekdays and weekends (Figure 1). 
Actigraphy is helpful to supplement the sleep diary, especially if the history is 
unreliable. Melatonin levels, through salivary or plasma sampling, may show 
early melatonin onset or earlier phase of melatonin metabolite excretion via 
urinary 6-sulfatoxymelatonin, although these tests are not widely available for 
clinical purposes [2, 3, 9].
5.2 Delayed sleep-wake phase disorder (DSWPD)
DSWPD is a clinical diagnosis and should be suspected when individuals report 
consistent bedtime and wake times that are significantly later than social norms. 
Bedtimes are often more informative than wake times, which are usually dictated 
by social or work/school obligations. It is also helpful to ask about sleep patterns 
during weekends, and during unrestricted periods such as vacations, when patients 
are able to sleep based on their own circadian preference (Figure 2). Sleep logs 
of at least 7 days, including both school/workdays and weekends, are needed to 
identify specific patterns [9]. It is important to inquire about other social factors, 
such as caffeine use later in the day, or excessive use of light-emitting devices before 
bedtime, which can also delay sleep onset.
Wrist actigraphy is another means of obtaining more quantitative data [9]. If 
the actigraph has a photo sensor it can provide information about the correlation 
between an individual’s light exposure and sleep time. Polysomnography is not 
typically indicated, unless there is clinical suspicion for another comorbid sleep 
disorder, such as sleep-disordered breathing. Salivary melatonin assays are avail-
able; however, these assays are used primarily as research tools and not for clinical 
diagnosis.
Figure 1. 
This 14-day sleep diary of a patient with advanced sleep–wake phase disorder (ASWPD) depicts an early 
sleep onset (7-8 pm) and early wake time (3-4 am). The total duration of sleep time (shaded box) remains 
normal at 7-8 hours. Individuals with ASWPD usually do not have symptoms if they are allowed to sleep per 
their preferred schedule; however, when tasked with staying up later than their usual bedtime, they can have 
significant difficulty. This circadian rhythm is more prevalent in older adults who may not have the same work 
or school obligations (“ret” represents “retired”) that can contribute to other circadian rhythm disorders, such as 




5.3 Irregular sleep-wake rhythm disorder (ISWRD)
The diagnosis of ISWRD is made by clinical history, with supplemental informa-
tion from wrist actigraphy. There must be a reported chronic or recurrent pattern of 
irregular sleep and wake episodes throughout a 24-hour period, with a minimum of 
3 cycles occurring during that time (Figure 3). A sleep log, and/or actigraphy must 
document these cycles for at least 7 days (preferably 14 days), and symptoms must 
be present for at least 3 months [9].
Polysomnography is not usually indicated, unless there is concern that the sleep 
disturbance is better explained by another disorder (e.g., a sleep-related breathing 
disorder).
5.4 Non-24 sleep-wake rhythm disorder (N24SWRD)
Sleep diary and actigraphy are important in confirming a non-entrained 
sleep pattern and will also show a gradual drift of onset and offset of the sleep– 
wake rhythm (Figure 4). In order to appreciate the drift, this data should be 
obtained for at least 2 weeks, and symptoms should be present for at least 
3 months [9].
Other measurements such as continuous core body temperature or serial mea-
surements of melatonin can be confirmatory as they also exhibit a similarly non-
24-hour drifting rhythm. However, these procedures are not required to make the 
diagnosis of N24SWD.
Attention should be paid to distinguish N24SWD from DSWPD, as these 
patients can display a similar evening phenotype and up to 25% of N24SWD are 
often initially misdiagnosed as DSWPD [2, 3, 9].
Figure 2. 
This 14-day sleep diary of a patient with delayed sleep–wake phase disorder (DSWPD) depicts variable 
sleep depending on the day of the week. The upwards arrow indicates “time in bed” while the downwards 
arrow indicates “time out of bed”. The shaded area represents sleep time of the patient. For example, in this 
diagram, the individual goes to bed between 9 and 10 pm on school days but is not able to sleep until 2-3 am. 
Due to his fixed school start time, he has to get out of bed between 6 and 7 am, leaving only 4-5 hours of sleep 
time (shaded box). However, on weekends (Friday and Saturday nights), he goes to sleep at his desired time of 
2-3 am and wakes up at his desired time between 1 and 2 pm, accounting for a total sleep time of 10-11 hours. 
This variation in sleep pattern, based on day of the week, is classic for DSWPD, and results in the symptoms 
described by those with this condition.
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5.5 Shift work sleep-wake disorder (SWD)
SWD is best assessed through careful sleep history and sleep diary. Particular 
attention should be paid to a patient’s occupation, history with shift work disorder 
with prior jobs, and impaired task performance at work. Factors specific to the 
patient’s home environment (i.e. lack of dedicated dark space for sleeping, noise lev-
els during the day, etc.) can further reduce the likelihood that the patient can obtain 
restorative sleep. The clinical history should also inquire about features of other 
comorbid sleep, medical, and mental disorders. A sleep diary should be obtained 
for at least 2 weeks and should capture both work and non-work days [9]. Validated 
questionnaires, such as the Insomnia Severity Index and Epworth Sleepiness Scale, 
can be used but are not required to diagnose SWD.
Figure 4. 
This 14-day sleep diary of a patient with non-24 sleep–wake phase disorder (N24SWPD) depicts a gradual 
drift in onset and offset of the sleep duration (shaded box), usually by 30 minutes each day. In order to best 
appreciate this drift, a sleep diary or actigraphy should be obtained for at least 2 weeks, and ideally more if 
possible. This circadian rhythm disorder is most prevalent in individuals who are blind.
Figure 3. 
This 14-day sleep diary of a patient with irregular sleep-wake rhythm disorder (ISWRD) depicts an irregular 
pattern of sleep throughout each 24-hour period. During each day, there are at least 3 sleep cycles occurring in 
a recurrent, but irregular fashion. The total sleep duration (shaded box) is usually normal for an individual’s 





Wrist actigraphy, especially when performed with an actigraphy that includes 
a photosensor, can better quantify sleep duration. There is no need for polysom-
nography unless there is a clinical suspicion for a comorbid sleep disorder, such as 
a sleep-related breathing disorder. Melatonin sampling is done in research settings, 
but is not routinely used in the clinical setting.
5.6 Jet lag disorder (JLD)
Clinical history is the most important tool. The clinician should specifically 
obtain information about number of time zones crossed and the timeline of symp-
tom occurrence. JLD is often confused with travel fatigue since there are many over-
lapping symptoms; however, the distinction is that travel fatigue is not dependent 
on the number of time zones traveled and tends to resolve quicker.
Since JLD is transient, and clinical history is usually clear, there is typically no 
role for formal diagnostic testing.
6.  If you decide the patient has a circadian rhythm sleep-wake disorder, 
how should the patient be managed?
6.1 Advanced sleep-wake phase disorder (ASWPD)
Bright light therapy in the early evening is the primary treatment for ASWPD, 
with the goal to delay the circadian phase so it is better aligned to desired sleep and 
wake times [5, 9]. Patients should use a bright light that filters out ultraviolet rays 
(2,500 to 10,000 lux) for 1-3 hours per day, starting at the time when they first 
experience sleepiness in the evening (usually around 7-9 pm). This should be done to 
gradually delay bedtime by 1-2 hours each day until desired times are met (Figure 5).
There is no strong evidence to support pharmacologic therapy in ASWPD. Melatonin 
in the morning can theoretically shift the clock to a later phase, however the sedating 
effect of melatonin often limits morning use. Early morning hypnotics to resume sleep 
can lead to daytime grogginess and hangover effect and thus are generally discouraged.
Figure 5. 
For individuals with advanced sleep–wake phase disorder (ASWPD), bright light therapy should be given for 
1-3 hours per day in the evening starting at the time of sleepiness. This will gradually shift the sleep time until 
the desired schedule is met.
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6.2 Delayed sleep-wake phase disorder (DSWPD)
Management of DSWPD consists of behavioral modifications to realign one’s 
circadian system with desired sleep–wake times, and concurrent melatonin use and 
light therapy. Easily modifiable behaviors should be targeted first. These behaviors 
include avoiding daytime naps, eliminating excessive use of caffeine and/or alco-
hol, reducing stimulating activity, and minimizing light (particularly blue light) 
exposure 2 hours prior to bedtime.
For those who fail to respond to behavioral therapies alone, timed melatonin can 
supplement these behavioral modifications. One reasonable approach would be to 
take melatonin daily, approximately 3-5 hours prior to desired sleep time [5]. Doses 
may vary from 0.5-5 mg, though it is best to use the lowest effective dose. Melatonin 
dose and timing can be strategically adjusted based on clinical response. Relapse 
tends to occur in high rates (80-90%) once melatonin is discontinued [3, 5].
Morning light therapy can be coupled with the above interventions. Commercial 
light boxes that either contain a broad spectrum of white light or narrow spectrum 
of blue light (2,000-10,000 lux) should be used every morning between just after 
typical wake-up time, with gradual advancing of the sleep–wake time until the 
desired time is reached [5, 9]. Care should be taken to avoid light exposure earlier 
than 2-3 hours before the habitual wake up time because light prior to the core body 
temperature minimum may cause further delays in circadian phase (Figure 6).
6.3 Irregular sleep–wake rhythm disorder (ISWRD)
Treatment of ISWRD involves using behavioral strategies to restructure an 
individual’s daily routine, and to optimize sleep hygiene to better consolidate sleep 
times and improve daytime alertness. It is important to create a cognitively enriched 
and socially interactive environment during the day to maintain alertness and 
prevent excessive napping. At night, measures should be taken to reduce noise and 
light, and to prevent sleep disturbances caused by other factors (e.g., nocturia).
Figure 6. 
For individuals with delayed sleep–wake phase disorder (DSWPD), treatment can consist of low-dose 
melatonin (to be taken ~3-5 hours prior to desired sleep time), along with phototherapy in the morning upon 




Light therapy remains the most effective intervention during the day. Exposure 
to 3,000-5,000 lux of light for at least 2 hours in the morning has been shown to 
improve daytime alertness, reduce napping, and consolidate nightly sleep [5].
Melatonin can also be used for management of ISWRD, though positive results 
with melatonin use are less consistent than with treatment of other CRSWDs. 
Melatonin doses of 1-5 mg can be used 30 min prior to bedtime to facilitate sleep, 
and melatonin is more effective if used in conjunction with light therapy [3, 5]. 
Controlled-release formulation can be more effective than immediate release in this 
specific patient population with ISWRD.
6.4 Non-24 sleep-wake rhythm disorder (N24SWRD)
Treatment for N24SWD includes attempting to re-synchronize the circadian 
pacemaker using behavioral approaches and pharmacologic therapy. Education 
regarding proper sleep hygiene and maintenance of regularly scheduled timing of 
meals, social activities and physical exercise is important.
Tasimelteon, a melatonin agonist with affinity for the MT1 and MT2 recep-
tors, is Food and Drug Administration (FDA) approved for use in N24SWD 
[5]. Melatonin can also be used to achieve gradual re-alignment. Higher doses 
(3-10 mg) may be given 1-2 hours prior to the desired bedtime for the first month. 
Entrainment usually occurs within 5-10 weeks, after which low-dose melatonin 
(0.5-1 mg) should be maintained to prevent relapse [5, 7].
Less robust evidence exists for bright light therapy, though it has been shown 
to be effective in sighted individuals with N24SWD and can be used in the early 
morning after awakenings.
6.5 Shift work sleep-wake disorder (SWD)
Management of SWD should first start with changes to work schedule, if pos-
sible, with adjustments to sleep hygiene. A regular daytime sleep schedule that can 
be followed, even during non-working days, is recommended to promote stability to 
the circadian system. This can be organized around an individual’s personal sched-
ule, but should ideally incorporate at least a 5 to 6-hour block of uninterrupted 
sleep. The sleep environment should be optimized to reduce sound, light, unfavor-
able temperatures and other factors that can interfere with sleep. Light blocking 
window shades can be used, and a temperature setting between 65 and 70 degrees 
Fahrenheit is optimal.
While at work, individuals can use continuous exposure to high-intensity light 
(2,000-10,000 lux) for as little as four 20-minute periods during the first part of 
the nigh [8] t. Use of blue light-blocking goggles in the morning and general avoid-
ance of morning light help the circadian rhythm remain adapted to the shift work 
schedule. Additionally, short naps (<45 minutes) prior to the start of the work 
shift are a low-risk intervention that can be used to promote wakefulness during 
the shift.
If these behavioral measures fail, medication therapy is the next step. 
Modafinil (200 mg) and armodafinil (150 mg) are FDA approved for shift work 
disorder and can be used during the first part of the night [5, 8]. Small doses 
of caffeine (100-250 mg, equivalent to a small cup of coffee) can also be used 
during the first part of the night. Short-acting hypnotics such as zolpidem and 
zaleplon can be used to promote sleep during the daytime; use of hypnotics must 
be introduced cautiously to prevent nocturnal grogginess (during work hours). 
Exogenous melatonin 30 min prior to desired bedtime can be used, although the 
evidence for this is poor [5].
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6.6 Jet lag disorder (JLD)
The treatment strategy depends on the length of trip, number of time zones trav-
eled, and direction of travel [9]. Trips less than 3 days are usually too short to create 
problematic jet lag symptoms. Treatment planning is best done in anticipation of travel.
For eastward travel on trips longer than 3 days and up to 7 time zones, a strategy 
using timed light exposure and melatonin can help advance the circadian rhythm 
(making natural bedtime and wake time earlier) to the new time zone. Bright light 
therapy can be started up to 3 days prior to departure to start the advancing process. 
Individuals should wake up about 1 hour prior to usual wake-up time and expose 
themselves to bright light for at least an hour. Upon arrival at destination, strategic 
light exposure throughout the afternoon and light avoidance during the early morning 
can help with this circadian realignment. The specific timing of light exposure is based 
on when the patient’s habitual core body temperature minimum (CBT-min) occurs, 
which is usually 3 hours before habitual wake-up time. Light exposure after the CBT-
min causes circadian phase advancement, whereas light exposure before the CBT-min 
causes a circadian phase delay and is thus counterproductive for eastward travel [8].
Timed melatonin (3-5 mg) taken at the desired destination bedtime can be used 
concurrently with prescribed light exposure. Melatonin should first be taken on 
the evening of arrival and continued for up to 5 days. Hypnotics have been used 
by patients during travel, but these medications can lead to impaired daytime 
performance, and thus are generally not recommended for management of JLD. 
Caffeine can help mitigate daytime sleepiness. Other stimulants (e.g. modafinil, 
armodafinil) can offset daytime sleepiness though these medications are not 
FDA approved for JLD. For eastward travel that crosses more than 8 time zones, 
it is often easier to pursue a circadian phase delay, rather than a circadian phase 
advance, to mitigate symptoms of JLD. This approach generally involves seeking out 
early morning light at the destination and avoiding light exposure in the afternoon.
Westward travel requires a delay in the circadian rhythm (later bed times and 
wake times) to adjust to the destination time zone. It is advised to seek bright light 
before the calculated CBT-min at the destination (based on the home time zone). 
For example, if one’s habitual wake up time in Boston is 8 am Eastern Standard 
Time (EST), the habitual CBT-min will be at 5 am EST. If that individual travels to 
Westward to Hawaii (5-hour time zone delay), the CBT-min will occur at midnight 
EST, thus bright light exposure should be given prior to that time. Melatonin or 
hypnotics are generally not required in JLD associated with westward travel.
Resources such as www.jetlagrooster.com and the British Airways jet lag 
advisor [10] can help individuals plan light and melatonin exposure including in 
preparation for travel.
7.  How do patients generally respond to treatment? What other 
considerations exist for patients with circadian rhythm disorders?
Treatment of circadian rhythm sleep wake disorders can often be challenging, 
and requires an individualized and multimodal approach, incorporating behavioral 
strategies such as directed light exposure, and appropriately timed melatonin. 
Overall effectiveness can be improved by combining these measures with chrono-
therapy, which gradually and progressively shifts the circadian clock.
Patients tend to respond well initially, however often require significant personal 
investment to maintain their newly desired schedule, and relapse to prior sleep sched-
ule is not uncommon. It is essential to have the support of family, friends, teachers 
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When treating circadian rhythm sleep wake disorders, it is important to opti-
mize the treatment of other comorbid medical conditions, especially psychiatric 
and mood disorders. This is especially true in adolescents and older patients. The 
importance of addressing sleep hygiene and one’s sleep environment cannot be 
overstated as a critical component of treatment.
The treatment of CRSWDs remain a challenge, in part because of the scarcity 
of large, multicenter placebo-controlled trials using phototherapy and pharmaco-
therapy. However there have been recent rapid advances in our understanding of 
the genetics of circadian rhythm regulation, which may lead to improved diagnostic 
tools and treatments. For example, technology involving DNA manipulation has 
been used to generate Cry1/Cry2 knockout animals to further study the expres-
sion of specific genes on circadian function [11]. This opens up avenue for new 
therapeutic approaches in many disorders, specifically neuropsychiatric conditions, 
associated with circadian rhythm disturbance.
8. Conclusions
Circadian rhythm disorders are common conditions that occur as a result of 
misalignment between an individual’s intrinsic time-keeping system, and extrinsic 
cues. There are usually multifactorial contributions, including genetic influences, 
and behaviorally induced elements. Effective treatment approaches largely revolve 
around strategically timed melatonin and phototherapy to shift one’s sleep phase to 
a more desired time. Consultation with a sleep medicine clinician may be helpful if 
symptoms persist, or to clarify a suspected circadian rhythm disorder.
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